Contact
searchSearch
HMP Global

April 2013 - FRMC

Department
Oral Therapy for Chronic Weight Management - Qsymia® (phentermine and topiramate extended-release) capsules
04/22/2013
The FDA approved Qsymia® (phentermine and topiramate extended-release) capsules in July 2012 as an adjunct to a reduced calorie diet and increased physical activity for chronic weight management in people with a body mass index ≥30 kg/m2...
The FDA approved Qsymia® (phentermine and topiramate extended-release) capsules in July 2012 as an adjunct to a reduced calorie diet and increased physical activity for chronic weight management in people with a body mass index ≥30 kg/m2...
The FDA approved Qsymia®...
04/22/2013
First Report Managed Care
Department
Infliximab for Treatment-Resistant Depression
04/22/2013
About one third of depressed patients fail to respond to conventional antidepressant medication. It is believed that inflammation is a possible mechanism that contributes to this treatment resistance. A number of inflammatory biomarkers...
About one third of depressed patients fail to respond to conventional antidepressant medication. It is believed that inflammation is a possible mechanism that contributes to this treatment resistance. A number of inflammatory biomarkers...
About one third of depressed...
04/22/2013
First Report Managed Care
Cardiovascular Events and Polycythemia Vera
04/22/2013
Polycythemia vera is a rare hematologic neoplasm characterized by clonal proliferation of multipotent bone marrow progenitors, leading to abnormal production of erythroid cells and an increased red-cell mass. Acquired mutations in JAK2 (JAK2...
Polycythemia vera is a rare hematologic neoplasm characterized by clonal proliferation of multipotent bone marrow progenitors, leading to abnormal production of erythroid cells and an increased red-cell mass. Acquired mutations in JAK2 (JAK2...
Polycythemia vera is a rare...
04/22/2013
First Report Managed Care
Costs of Biologics to Treat Psoriasis
04/22/2013
Miami Beach—During a 10-year period, the average direct costs per patient with moderate-to-severe psoriasis who took biologics were nearly $200,000 regardless of the drug they were prescribed, while productivity losses averaged around...
Miami Beach—During a 10-year period, the average direct costs per patient with moderate-to-severe psoriasis who took biologics were nearly $200,000 regardless of the drug they were prescribed, while productivity losses averaged around...
Miami Beach—During a 10-year...
04/22/2013
First Report Managed Care
Analysis of Acitretin to Treat Psoriasis
04/22/2013
Miami Beach—An analysis of national survey data found that patients with psoriasis typically use acitretin in combination with other agents. However, women of childbearing potential are typically not prescribed the drug due to serious side...
Miami Beach—An analysis of national survey data found that patients with psoriasis typically use acitretin in combination with other agents. However, women of childbearing potential are typically not prescribed the drug due to serious side...
Miami Beach—An analysis of...
04/22/2013
First Report Managed Care
Patients with TTR Amyloidosis Using Pacemakers
04/22/2013
San Francisco—Patients with transthyretin (TTR) amyloidosis who had pacemakers were more likely to be older and male, and have greater beta-blocker use, greater left ventricular septal thickness, and higher brain natriuretic peptide levels...
San Francisco—Patients with transthyretin (TTR) amyloidosis who had pacemakers were more likely to be older and male, and have greater beta-blocker use, greater left ventricular septal thickness, and higher brain natriuretic peptide levels...
San Francisco—Patients with...
04/22/2013
First Report Managed Care
PCI versus Pharmaco-Invasive Regimen in STEMI Patients
04/22/2013
San Francisco—Patients with ST-elevation myocardial infarction (STEMI) treated at community hospitals or in ambulances had similar results whether they underwent percutaneous coronary intervention (PCI) or received a pharmaco-invasive...
San Francisco—Patients with ST-elevation myocardial infarction (STEMI) treated at community hospitals or in ambulances had similar results whether they underwent percutaneous coronary intervention (PCI) or received a pharmaco-invasive...
San Francisco—Patients with...
04/22/2013
First Report Managed Care
Integrated Healthcare System’s Effect on Clinical and Economic Results
04/22/2013
San Francisco—A retrospective cohort study found that for patients with atrial fibrillation and atrial flutter, a closed system healthcare model was associated with significantly lower costs compared with an open system model over a 12-month...
San Francisco—A retrospective cohort study found that for patients with atrial fibrillation and atrial flutter, a closed system healthcare model was associated with significantly lower costs compared with an open system model over a 12-month...
San Francisco—A retrospective...
04/22/2013
First Report Managed Care
Ranolazine for Type 2 Diabetes, Coronary Artery Disease, and Chronic Stable Angina
04/22/2013
San Francisco—Patients with type 2 diabetes, coronary artery disease, and chronic stable angina who took ranolazine had fewer angina episodes and fewer sublingual nitroglycerin dosages compared with a group receiving placebo, according to a...
San Francisco—Patients with type 2 diabetes, coronary artery disease, and chronic stable angina who took ranolazine had fewer angina episodes and fewer sublingual nitroglycerin dosages compared with a group receiving placebo, according to a...
San Francisco—Patients with type...
04/22/2013
First Report Managed Care
Eplerenone in STEMI Patients with No History of Heart Failure
04/22/2013
San Francisco—After a mean follow-up of 10.5 months, patients with acute ST-segment elevation myocardial infarction (STEMI) who, having no diagnosis of heart failure, took eplerenone in addition to standard treatment had a significant...
San Francisco—After a mean follow-up of 10.5 months, patients with acute ST-segment elevation myocardial infarction (STEMI) who, having no diagnosis of heart failure, took eplerenone in addition to standard treatment had a significant...
San Francisco—After a mean...
04/22/2013
First Report Managed Care
FRMC Volume 21, Issue 4

Current Issue

October/November/December Volume 21, Issue 4, First Report Managed Care
Current Issue
Issue Archive

What's Trending?

News
Understanding the Link Between bDMARD Initiation, Switching With Mood Disorders
10/02/2020
Researchers found a positive association between the use of antidepressant and anxiolytic medication with both the introduction and switching of bDMARDs.
Researchers found a positive association between the use of antidepressant and anxiolytic medication with both the introduction and switching of bDMARDs.
Researchers found a positive...
10/02/2020
First Report Managed Care
News
Medicare wants pharmacists out of Plan D decision-making process
12/15/2010
12/15/2010
First Report Managed Care
News Connection
Travel, Wait Times Cost $89 Billion Annually for Health Care Service
03/20/2019
According to survey data from the Bureau of Labor Statistics’ American Wait Time Use Survey, spanning 2006 through 2017, travel and wait times were highest for health care services, ranked above legal services, personal care, vehicular...
According to survey data from the Bureau of Labor Statistics’ American Wait Time Use Survey, spanning 2006 through 2017, travel and wait times were highest for health care services, ranked above legal services, personal care, vehicular...
According to survey data from...
03/20/2019
First Report Managed Care
News
Even When Employed, Health Care A Challenge
02/23/2012
02/23/2012
First Report Managed Care
News
Limited HIV Resources Best Invested in Community-Based Prevention Education
10/16/2015
Researchers suggest that funds for HIV treatment and prevention should focus first on effective, inexpensive community-based education for HIV prevention efforts.
Researchers suggest that funds for HIV treatment and prevention should focus first on effective, inexpensive community-based education for HIV prevention efforts.
Researchers suggest that funds...
10/16/2015
First Report Managed Care

Video Insights

Formoso Headshot
Videos
Minimally Invasive Solutions for Lumbar Disc Herniation
01/07/2025
In this interview, Ferdinand Formoso, DO, discusses the role of condoliase as a minimally invasive treatment for lumbar disc herniation, its safety profile, potential areas for further research, and its ability to address unmet needs in spine...
In this interview, Ferdinand Formoso, DO, discusses the role of condoliase as a minimally invasive treatment for lumbar disc herniation, its safety profile, potential areas for further research, and its ability to address unmet needs in spine...
In this interview, Ferdinand...
01/07/2025
First Report Managed Care
Kolodziej Headshot
Videos
Navigating Biosimilar Adoption: Lessons from Global Markets and Clinical Practices
12/20/2024
In this interview, Michael Kolodziej, MD, discusses strategies for enhancing biosimilar adoption in the US, emphasizing lessons from global markets, the importance of payer flexibility, and the need for collaboration to reduce costs and...
In this interview, Michael Kolodziej, MD, discusses strategies for enhancing biosimilar adoption in the US, emphasizing lessons from global markets, the importance of payer flexibility, and the need for collaboration to reduce costs and...
In this interview, Michael...
12/20/2024
First Report Managed Care
Mike Kolodziej, MD
Videos
Exploring Biosimilar Adoption and Policy Impacts in Oncology
12/18/2024
In this interview, Michael Kolodziej, MD, discusses the role of biosimilars in value-based care models, their relationship with targeted therapies, and the impact of policy changes and market trends on biosimilar adoption and cost...
In this interview, Michael Kolodziej, MD, discusses the role of biosimilars in value-based care models, their relationship with targeted therapies, and the impact of policy changes and market trends on biosimilar adoption and cost...
In this interview, Michael...
12/18/2024
First Report Managed Care
Hennessy Headshot
Videos
Navigating Biosimilar Integration: Cost Savings, Coverage, and Future Strategies for Payers
12/10/2024
John Hennessy, MBA, discusses the complexities of biosimilar adoption, highlighting potential cost savings, payer strategies, challenges in provider and patient acceptance, regulatory impacts, and the critical need for sustainable market...
John Hennessy, MBA, discusses the complexities of biosimilar adoption, highlighting potential cost savings, payer strategies, challenges in provider and patient acceptance, regulatory impacts, and the critical need for sustainable market...
John Hennessy, MBA, discusses...
12/10/2024
First Report Managed Care
Videos
Bridging the Gaps in Prior Authorization: Challenges, Solutions, and Collaboration for Better Patient Care
11/13/2024
David Sand, MD, MBA, chief medical officer at ZeOmega, discusses the challenges of prior authorization, emphasizing the need for transparency, evidence-based standards, collaboration between payers and providers, and the potential for...
David Sand, MD, MBA, chief medical officer at ZeOmega, discusses the challenges of prior authorization, emphasizing the need for transparency, evidence-based standards, collaboration between payers and providers, and the potential for...
David Sand, MD, MBA, chief...
11/13/2024
First Report Managed Care
Richard Lipton, MD
Videos
The Evolving Role of CGRP-targeting Therapies in Migraine Prevention
10/31/2024
Richard Lipton, MD, provides insights on the American Headache Society’s position statement update on calcitonin gene-related peptide (CGRP)-targeting therapies as a first-line option for the prevention of migraine.
Richard Lipton, MD, provides insights on the American Headache Society’s position statement update on calcitonin gene-related peptide (CGRP)-targeting therapies as a first-line option for the prevention of migraine.
Richard Lipton, MD, provides...
10/31/2024
First Report Managed Care
Alexander Spira, MD, PhD
Videos
Unmet Needs in the Treatment and Management of Non–Small Cell Lung Cancer
09/26/2024
Alexander I. Spira, MD, PhD, discusses significant unmet needs in the treatment and management of non–small cell lung cancer (NSCLC).
Alexander I. Spira, MD, PhD, discusses significant unmet needs in the treatment and management of non–small cell lung cancer (NSCLC).
Alexander I. Spira, MD, PhD,...
09/26/2024
First Report Managed Care
Videos
Treatment Options for NSCLC: A Discussion on Coverage, Clinical Outcomes, and Payer Perspectives
09/25/2024
Learn about research developments in 1L therapy for NSCLC patients with EGFR mutations and how outcomes may impact coverage and reimbursement decisions for insurers.
Learn about research developments in 1L therapy for NSCLC patients with EGFR mutations and how outcomes may impact coverage and reimbursement decisions for insurers.
Learn about research...
09/25/2024
First Report Managed Care
Title Card
Videos
Addressing the Root Cause of a Common Ocular Condition: A Virtual Roundtable
09/04/2024
View a roundtable discussion on Demodex blepharitis, a prevalent ocular condition that often goes undiagnosed in patients.
View a roundtable discussion on Demodex blepharitis, a prevalent ocular condition that often goes undiagnosed in patients.
View a roundtable discussion on...
09/04/2024
First Report Managed Care
Jordan Bazinsky
Videos
Addressing Health Disparities and Promoting Equity: The Role of Advanced Imaging Solutions
08/15/2024
Guest expert Jordan Bazinsky discusses the challenges facing the medical imaging industry, the potential of AI and emerging technologies, the role of advanced imaging solutions in promoting health equity, and the key trends and challenges...
Guest expert Jordan Bazinsky discusses the challenges facing the medical imaging industry, the potential of AI and emerging technologies, the role of advanced imaging solutions in promoting health equity, and the key trends and challenges...
Guest expert Jordan Bazinsky...
08/15/2024
First Report Managed Care

Subscribe to our eNewsletters!

First Report Managed Care Newsletter

April 2013 Volume 10 Issue 4

View Issue Archive
Editorial Correspondence

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use